Neogen Corporation (NEOG)

Food and animal safety diagnostics maker. Read November 9, 2026 from the annual report for the period ending May 31, 2026, filed July 30, 2026. Ranked 73 of the 145 Healthcare companies read so far, by the share within reach now.

The filing states 2,636 employees at May 31, 2026, 1,346 in North America and about 1,257 in manufacturing and services, and describes food and animal safety diagnostics, chemicals and genomics services, so the diagnostics lead at pharmaceutical manufacturing with the chemicals and the testing labs beside them by description.

The figures on this page come from the company's own annual report and from BLS staffing patterns for its industries, never from a roster. They are estimates with a stated method. Nothing here says what the company will do: within reach is not a forecast of jobs lost or of savings.

What follows from the reading

Share of working time within reach of AI, on the long-run pace at four in five: 33% now, 43% at the end of 2027, 46% at the end of 2028, 47% at the end of 2030. By the patterns, the work is about 47% desk work, 14% people work and 39% body work. These are the site's industry estimates weighted by the shares below: estimates with a stated method and range, not a forecast of what the company will do. By the same patterns, at the end of 2028 about 54% of the working time stays with people (conversation, in-person and hands-on work), 41% becomes checking a model's work and 5% could be handed over with lighter checks, from the industries' own figures, not the company's roles.

Headcount

2,636 employees as of May 31, 2026 (stated). Not stated as a U.S. figure: 1,346 of 2,636 employees are in North America and 1,290 international.

The filing: “As of May 31, 2026, we employed 2,636 people worldwide, with 1,346 located in North America and 1,290 international.”

The workforce as industry patterns

What the filing says about the workforce: 2,636 employees worldwide at May 31, 2026, down from 2,974: 1,346 in North America and 1,290 international; approximately 1,257 full-time employees in manufacturing operations and services on multiple shifts; union and non-union employees; the Neogen DNA framework of Purpose, Principles and Values.

Companies read with the same leading pattern

Other companies whose largest staffing pattern is also Pharmaceutical and Medicine Manufacturing, largest first, each read from its own annual report. Within reach now and at the end of 2028, long-run pace, four in five. Now is projected from METR's April 2026 measurement and Epoch's November 2026 index.

• Johnson & Johnson (JNJ, 140,800 employees)30% now, 41% by 2028
• Thermo Fisher Scientific Inc. (TMO, 125,000 employees)36% now, 53% by 2028
• Merck & Co., Inc. (MRK, 75,000 employees)32% now, 44% by 2028
• Pfizer Inc. (PFE, 75,000 employees)32% now, 44% by 2028
• AbbVie Inc. (ABBV, 57,000 employees)32% now, 44% by 2028
• Eli Lilly and Company (LLY, 50,000 employees)32% now, 44% by 2028
• Bristol-Myers Squibb Company (BMY, 32,500 employees)32% now, 44% by 2028
• Amgen Inc. (AMGN, 31,500 employees)32% now, 44% by 2028

What the filing says about AI

3 sentences in the filing name AI. The filing names AI in its risk factors: rapid developments in artificial intelligence may disrupt its markets, the food and animal safety industries are increasingly influenced by AI and machine learning, and AI use brings operational, cybersecurity, privacy and regulatory risks.

• “Rapid developments in artificial intelligence and other emerging technologies may disrupt our markets, affect our competitive position and create new risks for our business.”
• “The food and animal safety industries in which we operate are increasingly influenced by artificial intelligence ("AI"), machine learning and other emerging technologies.”
• “In addition, the use of AI presents operational, cybersecurity, data privacy and regulatory risks, including the risk that AI-generated outputs may be inaccurate or unreliable and that evolving laws and regulations may increase compliance costs or restrict our use of AI.”

Its annual reports, year by year

Sentences naming AI in each annual report, counted by one rule, beside the median report in the Index that year. Each count links its filing. Every company, by year and sector

• Fiscal 20210median 0
• Fiscal 20220median 0
• Fiscal 20230median 1
• Fiscal 20240median 4
• Fiscal 20253median 10

Headcount by filing year

As reported in each year's annual report, with the filing. A year marked not read had no figure the reading could take from the report's text.

Limits of this reading

• The filing counts the manufacturing and service employees but nothing by product line, so the split among diagnostics, chemicals and testing services is by description (c).
• The U.S. share is not stated apart from North America.
• The union share is stated in words (union and non-union employees) and left null.

Source: the company's annual report on EDGAR, accession 0001193125-26-326092, the filing. Read by Claude Fable 5.1 under rubric version 1, by the method. A company can write to info@stratussc.com to have its reading checked against its filing.